The first Beam Therapeutics trade was made in Q2 2020.
Since then Steven Cohen bought shares two more times and sold shares on three occasions. The investor completely sold their stake between Q1 2022 and Q2 2022.
Avg closing price
Price range
Sold -24.3 Thousand shares
Q2 2022
Avg closing price
$39.75
Price range
$29.86
-
$62.36
Sold 45.9% shares (-20.6 Thousand shares)
Q1 2022
Avg closing price
$65.59
Price range
$53.73
-
$82.16
New holding (+44.9 Thousand shares)
Q4 2021
Avg closing price
$85.62
Price range
$68.02
-
$99.06
Sold -248 Thousand shares
Q4 2020
Avg closing price
$49.18
Price range
$22.24
-
$95.63
Increased shares by 68.0% (+101 Thousand shares)
Q3 2020